Released on: October 8, 2007, 12:58 pm

Press Release Author: GTCbio

Industry: Biotech

Press Release Summary: SVP and Site Head of Pfizer La Jolla announced as Plenary
Keynote Speaker for the 3rd Modern Drug Discovery & Development Summit (M3D).

Press Release Body: MONROVIA, CA - Dr. Keith James, Senior Vice President and Site
Head of Pfizer La Jolla is presenting at the Plenary Keynote session at GTCbio's 3rd
Modern Drug Discovery and Development Summit on November 28-30, 2007 at the Hyatt
Regency San Francisco Airport.

Dr. James' presentation will focus on building and maintaining a high performance
research and development organization. He will discuss the operating model used at
Pfizer which includes approaches such as keeping the focus on the patient,
accountability for strategy and delivery, and the alignment of research, development
and commercial dimensions to ensure success. Dr. James' will also outline the
importance of implementing clear performance expectations for organizations of any
size.

The 3rd Modern Drug Discovery & Development Summit features over 150 speakers
participating in 6 concurrent conferences, 6 study sessions and 3 pre-conference
workshops. Tracks include Biological Therapeutics, Drug Delivery Technology,
Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and
Pharmaco - Kinetics, Dynamics, Genomics and Genetics. For more information, visit
www.gtcbio.com.


Web Site: http://www.gtcbio.com

Contact Details: GTCbio organizes conferences specifically for the biomedical and
biopharmaceutical industries. Our goal is to facilitate the exchange of
biopharmaceutical and biomedical intelligence between industry leaders, academic and
government organizations, and the financial community.

GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.

Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, raniah@gtcbio.com